Clin2
NCT07725809Possibly a fitRecruiting

Study of a new medicine for adults with overweight or obesity

OverweightObesityHealthy

Part of Hormones & metabolism clinical trials.

This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
57 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older and generally healthy.
  • Your body mass index (BMI) is between 27 and 45, or between 22 and 45 if you are Japanese.
  • You weigh more than 110 pounds (50 kg).
  • You are not pregnant, breastfeeding, or planning to become pregnant during the study.
  • You do not have a history of certain medical conditions, including problems with your stomach, pancreas, gallbladder, heart, liver, or mental health.
  • You do not have a personal or family history of a rare thyroid cancer (medullary thyroid carcinoma) or related syndrome.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07845513Not yet recruiting· Phase 1
Study of a new weight-loss medicine in Chinese adults

This study tests a new medicine (PF-08653944) for weight loss in Chinese adults who are overweight or have obesity. It aims to see if the medicine is safe and how it works in the body.

Beijing, Beijing Municipality
NCT07731139Recruiting· Phase 1
Testing a new medicine for people with obesity

This study tests how different amounts of the study medicine PF-08642534 are tolerated and how they work in the body of people with obesity. It aims to find a safe dose for future studies.

Lake Forest, California
NCT07566390Recruiting· Phase 1
Testing a new weight-loss medicine in healthy adults

This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.

Glendale, California
NCT07437079Recruiting· Phase 1
Testing a new weight-loss medicine in healthy people

This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.

Lenexa, Kansas
NCT07511205Recruiting· Phase 1
Study of AZD1043 for overweight or obesity

This trial tests a new medicine called AZD1043 in healthy adults who are overweight or have obesity. It aims to see if the medicine is safe and how the body handles it.

Glendale, California
NCT07339423Recruiting· Phase 3
A study of a new medicine for weight loss

This study tests a new medicine to see how well it helps people with excess body weight lose weight. It may be an option if you have tried to lose weight through dieting before but haven't had lasting success.

Miramar, Florida

Hear when a new Overweight trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.